Gary Bridger insider trades

Open-market stock purchases and sales by Gary Bridger, Director at X4 Pharmaceuticals, Inc, from SEC Form 4 filings since Mar 6, 2014.

Recent trades

DateStockTradeValue
Jan 1, 2026XFOR X4 Pharmaceuticals, IncBought (not open market)—

Companies traded

  • XFOR X4 Pharmaceuticals, Inc: other filings, last Jan 1, 2026
  • AQXP Aquinox Pharmaceuticals, Inc: other filings, last May 7, 2018
  • ALDR Alder Biopharmaceuticals Inc: 1 buy, last Oct 31, 2015
  • XENE Xenon Pharmaceuticals Inc: other filings, last Nov 21, 2014

Get free alerts when Gary Bridger files a new trade →